Position in EXEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,394,375
+$9,050,866 QoQ
Shares Held
312,296
+215.1% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 75.18027768527294.ToString("F0")%
Shared 0.ToString("F0")%
None 24.819722314727056.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. EXEL ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,394,375 | 312,296 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,343,509 | 99,099 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,109,600 | 75,293 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $3,118,483 | 70,746 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,356,123 | 63,817 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,846,718 | 55,457 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $919,408 | 35,430 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $765,373 | 34,062 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $768,994 | 32,406 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,246,256 | 51,949 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $916,061 | 41,925 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $360,949 | 18,888 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $330,610 | 17,033 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $219,010 | 13,654 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $247,210 | 15,766 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $122,733 | 5,895 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $234,702 | 10,353 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $191,958 | 10,501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $198,293 | 9,380 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $270,439 | 14,843 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $475,293 | 21,040 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $179,606 | 8,949 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $208,656 | 8,534 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $157,728 | 6,644 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $80,073 | 4,650 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||